Tag Archives: bayer

Reckitt Benckiser Signs $1.4 Billion Deal for Schiff Nutrition

Posted on November 22, 2012 by admin

Reckitt Benckiser Group PLC (RBGPY, RB.LN) signed a roughly $1.4 billion deal Wednesday to acquire Schiff Nutrition International Inc. Continue reading →

Posted in World News | Tagged , , , , , , , , , , , , , | Leave a comment

Bayer to Name Ex-CEO Wenning Chair of Supervisory Board -Report

Posted on September 12, 2012 by admin

German chemical and pharmaceutical company Bayer AG (BAYN.XE) plans Friday to name former Chief Executive Werner Wenning to chair its supervisory board, German daily Rheinische Post reported Wednesday, citing unnamed people close to the board. Continue reading →

Posted in World News | Tagged , , , , , , , , , , , , | Leave a comment

Bayer to Name Ex-CEO Chair of Supervisory Board

Posted on September 12, 2012 by admin

German chemical and pharmaceutical company Bayer AG (BAYN.XE) plans Friday to name former Chief Executive Werner Wenning to chair its supervisory board, German daily Rheinische Post reported Wednesday, citing unnamed people close to the board. Continue reading →

Posted in Stocks, World News | Tagged , , , , , , , , , , , , , | Leave a comment

Bayer Names Philip Blake Senior Bayer Representative USA

Posted on June 12, 2012 by admin

Blake assumes leadership of U.S. corporate functions from Greg Babe Also holds roles of Bayer HealthCare Representative U.S.A. and Head of … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , | Leave a comment

Bayer: Updated Phase III Data For Alpharadin Confirm Overall Survival Benefit

Posted on June 4, 2012 by admin

LEVERKUSEN (dpa-AFX) – Bayer HealthCare of Bayer AG (BYR.L, BAYRY.PK, BAYZF.PK) announced that updated data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAnce… Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

Studies Show Bayer, Boehringer Ingelheim Drugs Slow GIST, Lung-Cancer Growth

Posted on June 4, 2012 by admin

A study involving an experimental Bayer AG (BAYRY, BAYN.XE) cancer drug, regorafenib, showed it delayed the progression of a rare type of gastrointestinal tumor in patients who had been previously treated with other drugs. Continue reading →

Posted in Stocks, World News | Tagged , , , , , , , , | Leave a comment

Studies Show Bayer, Boehringer Ingelheim Drugs Slow GIST, Lung-Cancer Growth

Posted on June 4, 2012 by admin

A study involving an experimental Bayer AG (BAYRY, BAYN.XE) cancer drug, regorafenib, showed it delayed the progression of a rare type of gastrointestinal tumor in patients who had been previously treated with other drugs. Continue reading →

Posted in Stocks, World News | Tagged , , , , , , , , , , , , | Leave a comment

Johnson & Johnson Applies For Further FDA Approval Of Xarelto

Posted on May 2, 2012 by admin

Bayer AG (BAYN.XE) said Wednesday cooperation partner Johnson & Johnson (JNJ) has asked the U.S. Continue reading →

Posted in Stocks | Tagged , , , , , , , , , , , | Leave a comment

Bayer earnings hit by high-tech materials division

Posted on February 28, 2012 by admin

Flat sales at its materials division held down earnings at German pharmaceutical and chemicals firm Bayer AG as it recorded profit of euro397 million ($533 million) in the fourth quarter. Continue reading →

Posted in Stocks, World News | Tagged , , , , , , , | Leave a comment